Skip to Main Content

Paper Details

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine.
Front Immunol
5
2022
Author NameAffiliation
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Raveen RathnasingheGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Soner YildizIcahn School of Medicine at Mount Sinai
Soner YildizGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Lynda CoughlanUniversity of Maryland School of Medicine
Lynda CoughlanUniversity of Maryland School of Medicine
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Michael SchotsaertIcahn School of Medicine at Mount Sinai
Michael SchotsaertGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 13

Datasets

Release 1.2